Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	287
Number of pages	1
Journal	New England Journal of Medicine
Volume	390
Issue number	3
DOIs	https://doi.org/10.1056/NEJMc2313778
State	Published - 18 Jan 2024
Externally published	Yes

Access to Document

@article{289d8b928f6a485197aeb269b37c635c,

title = "Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.",

author = "Nobuyuki Horita and Yu Fujiwara",

year = "2024",

month = jan,

day = "18",

doi = "10.1056/NEJMc2313778",

language = "English",

volume = "390",

pages = "287",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "3",

}

TY - JOUR

T1 - Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.

AU - Horita, Nobuyuki

AU - Fujiwara, Yu

PY - 2024/1/18

Y1 - 2024/1/18

UR - https://www.scopus.com/pages/publications/85182767236

U2 - 10.1056/NEJMc2313778

DO - 10.1056/NEJMc2313778

M3 - Letter

C2 - 38231634

AN - SCOPUS:85182767236

SN - 0028-4793

VL - 390

SP - 287

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 3

ER -